Definition:Indicative offer letter
📝 Indicative offer letter is a preliminary, non-binding document submitted by a prospective acquirer expressing interest in purchasing an insurance company, MGA, book of business, or other insurance asset, along with a proposed valuation range and key transaction terms. Often referred to as an indication of interest (IOI) or non-binding offer (NBO), this letter typically arrives after the buyer has reviewed an information memorandum and initial data but before gaining access to a full due diligence data room. It serves as the buyer's ticket to the next phase of a structured sale process, signaling serious intent and providing the seller with enough detail to compare competing bids.
⚙️ A well-crafted indicative offer letter in an insurance context addresses several sector-specific dimensions beyond headline price. It outlines the buyer's view on key actuarial assumptions — particularly the treatment of reserves and any anticipated purchase price adjustments tied to reserve development — and indicates whether the proposed valuation is based on embedded value, a multiple of gross written premium, book value, or another metric. The letter also addresses regulatory considerations, including the buyer's plan for obtaining change-of-control approvals from insurance regulators, anticipated timelines, and any conditions precedent such as securing reinsurance or financing. Buyers frequently note their willingness (or lack thereof) to provide indemnity protections and describe the team and resources they will deploy for confirmatory due diligence.
💡 For sellers — whether they are insurance groups divesting non-core units, private equity sponsors exiting portfolio companies, or founders looking to monetize an insurtech platform — the indicative offer letter is the primary tool for sorting serious contenders from window-shoppers. Investment bankers running the process use these letters to create a shortlist of bidders who advance to detailed due diligence and management presentations. Because the letter is non-binding, its value lies not in legal enforceability but in the credibility of its terms: buyers who propose unrealistic valuations, vague regulatory strategies, or excessive conditionality risk being eliminated. In insurance M&A, where regulatory approval timelines can stretch for months and actuarial complexity adds layers of negotiation, a clear and well-informed indicative offer letter accelerates the process and sets the tone for the relationship between buyer and seller throughout the transaction.
Related concepts: